N-asetilsisteinle Ön-muamele Edilmiş Kardiyomyositlerden Salgılanan Eksozomların Yaşlanmaya Bağlı ROS Üretimi Üzerindeki Etkisi
Abstract
Objectives: In this study, it was aimed to investigate the regulatory effect of N-acetylcysteine (NAC), an antioxidant, on the aging-related reactive
oxygen species (ROS) production and mitochondrial membrane potential (MMP) in cardiomyocytes via exosomes released from cardiomyocytes at
the molecular level.
Materials and Methods: The aging model was performed by incubating rat left ventricular cell line H9c2 with D-galactose (D-Gal; 50 mg/mL) for
48 hours. Exosomes released from H9c2 pretreated with NAC were incubated with aged cardiomyocytes and their effects on the enhanced ROS
production and MMP depolarization with aging were compared with both normal control cells and aged cells without exosomes. ROS and MMP measurements were calculated relative to the confocal microscope using specific fluorescent dyes (DCFDA and FCCP) by visualizing the change in
fluorescence intensity. MiR-21 expression, which is also accepted as a ROS marker, and cDNA synthesis qRT-PCR measurements were performed
following exosomal miRNA isolation.
Results: Seventy-two-hour incubation of aging-modeled cardiomyocytes with exosomes isolated from H9c2 incubated with NAC significantly
suppresses the increased ROS production associated with aging and normalizes depolarized MMP. On the other hand, NAC treatment significantly
suppressed exosomal miR-21 expression in normal healthy cardiomyocytes.
Conclusion: These findings indicate that ROS-targeted agents used in the treatment of heart damage may specifically suppress mitochondrionderived
ROS production, which increases uncontrollably through an exosome-based paracrine mechanism. Our study also demonstrates, for the first
time in the literature, that NAC induces exosomal miRNA modulation in pretreated cardiomyocytes. These findings indicate that the administration
of exosomes obtained from cardiomyocytes with enhanced antioxidant system is a new treatment approach for aging-related inadequate heart
function.
Keywords
Aging, Cardiomyocyte, Exosome, Antioxidant, N-acetylcysteine, miR-21
References
- 1. Olgar Y, Degirmenci S, Durak A, et al. Aging related functional and structural changes in the heart and aorta: MitoTEMPO improves aged-cardiovascular performance. Exp Gerontol. 2018;110:172-181.
- 2. Bulthuis EP, Adjobo-Hermans MJW, Willems PHGM, et al. Mitochondrial Morphofunction in Mammalian Cells. Antioxid Redox Signal. 2019;30:2066-2109.
- 3. Wu NN, Zhang Y, Ren J. Mitophagy, mitochondrial dynamics, and homeostasis in cardiovascular aging. Oxid Med Cell Longev. 2019;2019:9825061.
- 4. Turan B. Role of antioxidants in redox regulation of diabetic cardiovascular complications. Curr Pharm Biotechnol. 2010;11:819-836.
- 5. Durak A, Olgar Y, Degirmenci S, et al. A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats. Cardiovasc Diabetol. 2018;17:144.
- 6. Olgar Y, Tuncay E, Degirmenci S, et al. Ageing-associated increase in SGLT2 disrupts mitochondrial/sarcoplasmic reticulum Ca2+ homeostasis and promotes cardiac dysfunction. J Cell Mol Med. 2020;24:8567-8578.
- 7. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A. 1994;91:10771-10778.
- 8. Ren J, Zhang Y. Targeting autophagy in aging and aging-related cardiovascular diseases. Trends Pharmacol Sci. 2018;39:1064-1076.
- 9. Stadtman ER. Protein oxidation and aging. Science. 1992;257:1220-1224.
- 10. Durak A, Bitirim CV, Turan B. Titin and CK2α are New Intracellular Targets in Acute Insulin Application-Associated Benefits on Electrophysiological Parameters of Left Ventricular Cardiomyocytes From Insulin-Resistant Metabolic Syndrome Rats. Cardiovasc Drugs Ther. 2020;34:487-501.